Cited by 1,115Pluripotent Stem Cells ResearchDevelopmental Biology and Gene RegulationCancer-related Molecular Pathways

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Open access

Kawamura, Teruhisa, Suzuki, Jotaro, Wang, Yunyuan V., Menendez, Sergio, Morera, Laura Batlle, Raya, Angel, Wahl, Geoffrey M., Belmonte, Juan Carlos Izpisúa·2009·Nature

DOI 10.1038/nature08311PMC PMC2735889

Open this paper in CoChat — free account

Abstract

Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes, but the low frequency and tendency to induce malignant transformation compromise the clinical utility of this powerful approach. We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells. Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway. Reducing signalling to p53 by expressing a mutated version of one of its negative regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency. Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimaeric mice using only Oct4 (also known as Pou5f1) and Sox2. Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells. These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature08311

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626

Show all 40 references

Sorted by citations

Items 601–700 of 1,000

In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status
Reid, P., Wilson, P., Li, Y., Marcu, L. G., Staudacher, A. H., Brown, M. P., & Bezak, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186186 · Cited by 22
CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells
Pratheeshkumar, P., Siraj, A. K., Divya, S. P., Parvathareddy, S. K., Alobaisi, K., Al-Sobhi, S. S., Al‐Dayel, F., & Al-Kuraya, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020504 · Cited by 22
Lung Cancer Stem Cells, p53 Mutations and MDM2
Gadepalli, V. S., Deb, S. P., Deb, S., & Rao, R. R. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_19 · Cited by 22
The cancer paradigms of mammalian regeneration: can mammals regenerate as amphibians?
Sarig, R., & Tzahor, E. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw103 · Cited by 22
A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications
Matiukhova, M., Ryapolova, A., Andriianov, V. S., Reshetnikov, V. V., Zhuravleva, S., Ivanov, R. A., Karabelsky, A. V., & Minskaia, E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1593207 · Cited by 25
Injury primes mutation-bearing astrocytes for dedifferentiation in later life
Ragdale, H. S., Clements, M., Tang, W., Deltcheva, E. M., Andreassi, C., Lai, A. G., Chang, W. H., Pandrea, M., Andrew, I., Gamé, L., et al. (2023) · Current Biology · doi:10.1016/j.cub.2023.02.013 · Cited by 20
Integrative Genomics in Combination with RNA Interference Identifies Prognostic and Functionally Relevant Gene Targets for Oral Squamous Cell Carcinoma
Xu, C., Wang, P., Liu, Y., Zhang, Y., Fan, W., Upton, M. P., Lohavanichbutr, P., Houck, J. R., Doody, D. R., Futran, N. D., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003169 · Cited by 22
Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells
Chang, G., Miao, Y., Zhang, Y., Liu, S., Kou, Z., Ding, J., Chen, D., Sun, Q., & Gao, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010320 · Cited by 21
Cell fate conversion: Direct induction of hepatocyte‐like cells from fibroblasts
Ji, S., Zhang, L., & Hui, L. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24380 · Cited by 21
Therapeutic opportunities: Telomere maintenance in inducible pluripotent stem cells
Gourronc, F. A., & Klingelhutz, A. J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.05.008 · Cited by 20
Micro-management of pluripotent stem cells
Guo, W., Wang, X., & Wang, Y. (2014) · Protein & Cell · doi:10.1007/s13238-013-0014-z · Cited by 21
Self-citation
The foundational framework of tumors: Gametogenesis, p53, and cancer
Liu, C., Moten, A., Ma, Z., & Lin, H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.018 · Cited by 21
Induced Pluripotent Stem Cells: Characteristics and Perspectives
Cantz, T., & Martin, U. (2010) · Springer eBooks · doi:10.1007/10_2010_74 · Cited by 23
Differential Expression of ID4 and Its Association with TP53 Mutation, SOX2, SOX4 and OCT-4 Expression Levels
Galatro, T. F. D. A., Uno, M., Oba‐Shinjo, S. M., de Almeida, A. N., Teixeira, M. J., Rosemberg, S., & Marie, S. K. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061605 · Cited by 21
Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic viruses
Iacovides, D. C., Michael, S., Achilleos, C., & Strati, K. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00066 · Cited by 21
Direct reprogramming 101
Takahashi, K. (2010) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2010.01169.x · Cited by 20
Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells
Naik, P. P., Panigrahi, S., Parida, R., Praharaj, P. P., Bhol, C. S., Patil, S., Manjunath, N., Ghosh, D., Patra, S. K., & Bhutia, S. K. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10216-9 · Cited by 20
B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors
Kaemena, D. F., Yoshihara, M., Beniazza, M., Ashmore, J., Zhao, S., Bertenstam, M., Olariu, V., Katayama, S., Okita, K., Tomlinson, S. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36097-9 · Cited by 20
Cell‐Reprogramming‐Inspired Dynamically Responsive Hydrogel Boosts the Induction of Pluripotency via Phase‐Separated Biomolecular Condensates
Zhu, F., Yan, N. J., Lu, X., Xu, J., Gu, H., Liang, J., Cheng, K., Wang, X., Ma, X., Ma, N., et al. (2023) · Advanced Materials · doi:10.1002/adma.202211609 · Cited by 20
Replication stress in mammalian embryo development, differentiation, and reprogramming
Wang, N., Xu, S., & Egli, D. M. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.03.015 · Cited by 21
Cellular Senescence in Cardiovascular Diseases: From Pathogenesis to Therapeutic Challenges
Li, D., Li, Y., Ding, H., Wang, Y., Xie, Y., & Zhang, X. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10100439 · Cited by 21
Self-citation
Telomere Biology in Stem Cells and Reprogramming
Batista, L. F. Z. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00003-7 · Cited by 22
Induced Pluripotent Stem Cells: A New Approach for Physiological Research
Pfannkuche, K., Hannes, T., Khalil, M., Noghabi, M. S., Morshedi, A., Hescheler, J., & Dröge, P. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000320514 · Cited by 21
Genome integrity: linking pluripotency and tumorgenicity
Deng, W., & Xu, Y. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.09.004 · Cited by 20
Suppression of Lefty expression in induced pluripotent cancer cells
Saito, A. M., Ochiai, H., Okada, S., Miyata, N., & Azuma, T. (2013) · The FASEB Journal · doi:10.1096/fj.12-221432 · Cited by 20
p16 Controls p53 Protein Expression Through miR-dependent Destabilization of MDM2
Al‐Khalaf, H. H., & Aboussekhra, A. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0017 · Cited by 22
Abnormal gametogenesis induced by p53 deficiency promotes tumor progression and drug resistance
Liu, C., Cai, Z., Jin, G., Peng, D., Pan, B., Zhang, X., Han, F., Xu, X., & Lin, H. (2018) · Cell Discovery · doi:10.1038/s41421-018-0054-x · Cited by 20
Targeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells
Wang, Y., Lü, T., Sun, G., Zheng, Y., Yang, S., Zhang, H., Hao, S., Liu, Y., Ma, S., Zhang, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13411-y · Cited by 20
Self-citation
Efficient Generation of Induced Pluripotent Stem Cells from Human Bone Marrow Mesenchymal Stem Cells
Yulin, X., Lizhen, L., Lifei, Z., Shan, F., Ru, L., Kaimin, H., & Huang, H. (2012) · Folia Biologica · doi:10.14712/fb2012058060221 · Cited by 20
The crosstalk between cellular reprogramming and senescence in aging and regeneration
Chiche, A., Chen, C., & Li, H. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111005 · Cited by 21
Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells
Lin, Y., Ku, C., Wuputra, K., Liu, C., Wu, D., Satou, M., Mitsui, Y., Saito, S., & Yokoyama, K. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105177 · Cited by 21
Advances and applications of induced pluripotent stem cells
Pietronave, S., & Prat, M. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-125 · Cited by 19
Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality
Cao, S., Loh, K. M., Pei, Y., Zhang, W., & Han, J. (2012) · Protein & Cell · doi:10.1007/s13238-012-2078-6 · Cited by 19
BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
Kim, E. J. Y., Änkö, M., Flensberg, C., Majewski, I. J., Geng, F., Firas, J., Huang, D. C. S., van Delft, M. F., & Heath, J. K. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.019 · Cited by 19
Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells
Phanthong, P., Raveh-Amit, H., Li, T., Kitiyanant, Y., & Dinnyés, A. (2013) · Biogerontology · doi:10.1007/s10522-013-9455-2 · Cited by 19
Reprogramming and the Pluripotent Stem Cell Cycle
Tsubouchi, T., & Fisher, A. G. (2013) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416027-9.00007-3 · Cited by 21
The H2B ubiquitin-protein ligase RNF40 is required for somatic cell reprogramming
Xie, W., Miehe, M., Laufer, S. D., & Johnsen, S. A. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2482-4 · Cited by 19
The Cyclin-Like Protein SPY1 Overrides Reprogramming Induced Senescence Through EZH2 Mediated H3K27me3
Lubanska, D., Qemo, I., Byrne, M., Matthews, K. N., Fifield, B., Brown, J. R., da Silva, E. F., & Porter, L. A. (2021) · Stem Cells · doi:10.1002/stem.3453 · Cited by 16
Concise Review: Induced Pluripotency by Defined Factors: Prey of Oxidative Stress
Qi, S., Fang, Z. H., Wang, D., Menéndez, P. R., Yao, K., & Ji, J. (2015) · Stem Cells · doi:10.1002/stem.1946 · Cited by 17
Late Passage Human Fibroblasts Induced to Pluripotency Are Capable of Directed Neuronal Differentiation
Liu, J., Sümer, H., Leung, J., Upton, K. R., Dottori, M., Pébay, A., & Verma, P. J. (2010) · Cell Transplantation · doi:10.3727/096368910x514305 · Cited by 18
Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications
Oh, S.-I., Lee, C. K., Cho, K. J., Lee, K.-O., Cho, S., & Hong, S. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/417809 · Cited by 18
Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
Grespi, F., Landré, V., Molchadsky, A., Daniele, N. D., Marsella, L., Melino, G., & Rotter, V. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.419 · Cited by 18
Highly efficient induction of primate iPS cells by combining RNA transfection and chemical compounds
Watanabe, T., Yamazaki, S., Yoneda, N., Shinohara, H., Tomioka, I., Higuchi, Y., Yagoto, M., Ema, M., Suemizu, H., Kawai, K., et al. (2019) · Genes to Cells · doi:10.1111/gtc.12702 · Cited by 19
Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes
Allen, J. E., Hart, L. S., Dicker, D. T., Wang, W., & El‐Deiry, W. S. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.22.10450 · Cited by 18
Apoptosis in MCF-7 breast cancer cells induced by S-alkenylmercaptocysteine (CySSR) species derived from Allium tissues in combination with sodium selenite
Zhang, W., Xiao, H., & Parkin, K. L. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.03.002 · Cited by 18
Impacts of and interactions between environmental stress and epigenetic programming during early embryo development
Bertoldo, M. J., Locatelli, Y., O’Neill, C., & Mermillod, P. (2014) · Reproduction Fertility and Development · doi:10.1071/rd14049 · Cited by 19
The Cell Biology of Stem Cells
Meshorer, E., & Plath, K. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4 · Cited by 20
RNA Genes: Retroelements and Virally Retroposable microRNAs in Human Embryonic Stem Cells~!2010-01-14~!2010-04-20~!2010-05-25~!
Fujii, Y. R. (2010) · The Open Virology Journal · doi:10.2174/1874357901004010063 · Cited by 18
The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential
Iglesias, J. M., Leis, O., Ruiz, E. P., Barrie, J. G., Garcia‐García, F., Aduriz, A., Beloqui, I., Hernández-García, S., Lopez-Mato, M. P., Dopazo, J., et al. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00308 · Cited by 18
A population of BJ fibroblasts escaped from Ras-induced senescence susceptible to transformation
Kohsaka, S., Sasai, K., Takahashi, K., Akagi, T., Tanino, M. A., Kimura, T., Nishihara, H., & Tanaka, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.082 · Cited by 18
Choosing Cell Fate Through a Dynamic Cell Cycle
Chen, X., Hartman, A. A., & Guo, S. (2015) · Current Stem Cell Reports · doi:10.1007/s40778-015-0018-0 · Cited by 19
RNA-Based Strategies for Cell Reprogramming toward Pluripotency
Bailly, A., Milhavet, O., & Lemaı̂tre, J.-M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020317 · Cited by 18
Molecular mechanisms of pluripotency and reprogramming
Na, J., Plews, J. R., Li, J., Wongtrakoongate, P., Tuuri, T., Féki, A., Andrews, P. W., & Unger, C. A. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt33 · Cited by 18
Indispensable role of Mdm2/p53 interaction during the embryonic and postnatal inner ear development
Laos, M., Sulg, M., Herranen, A., Anttonen, T., & Pirvola, U. (2017) · Scientific Reports · doi:10.1038/srep42216 · Cited by 17
Oocyte-Specific Homeobox 1, Obox1, Facilitates Reprogramming by Promoting Mesenchymal-to-Epithelial Transition and Mitigating Cell Hyperproliferation
Wu, L., Wu, Y., Peng, B., Hou, Z., Dong, Y., Chen, K., Guo, M., Li, H., Chen, X., Kou, X., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.012 · Cited by 17
Self-citation
The Histone Variant MacroH2A Blocks Cellular Reprogramming by Inhibiting Mesenchymal-to-Epithelial Transition
Pliatska, M., Καπασά, Μ., Kokkalis, A., Polyzos, A., & Thanos, D. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00669-17 · Cited by 17
AIMP3 depletion causes genome instability and loss of stemness in mouse embryonic stem cells
Kim, S. M., Jeon, Y., Kim, D., Jang, H., Bae, J. S., Park, M. K., Kim, H., Kim, S., & Lee, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1037-4 · Cited by 17
Reprogramming and transdifferentiation - two key processes for regenerative medicine
Hybiak, J., Jankowska, K., Machaj, F., Rosik, J., Broniarek, I., Żyluk, A., Hilderman, G. C., Małecki, A., Łoś, M., & Urasińska, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173202 · Cited by 20
Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion
Kwon, D., Ji, M., Lee, S., Seo, K. W., & Kang, K. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9697-x · Cited by 16
Implications of Cellular Aging in Cardiac Reprogramming
Passaro, F., & Testa, G. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00043 · Cited by 15
Dimerization choice and alternative functions of ZBTB transcription factors
Barakat, S., Ezen, E., Devecioğlu, İ., Gezen, M., Piepoli, S., & Erman, B. (2023) · FEBS Journal · doi:10.1111/febs.16905 · Cited by 16
The genomic stability of induced pluripotent stem cells
Chen, Z., Zhao, T., & Xu, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2922-8 · Cited by 16
The role of p53 in limiting somatic cell reprogramming
Liu, Y., Hoya-Arias, R., & Nimer, S. D. (2009) · Cell Research · doi:10.1038/cr.2009.121 · Cited by 18
Choreographing pluripotency and cell fate with transcription factors
Gonzales, K. A. U., & Ng, H. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.06.009 · Cited by 17
Cyclin A 1 Is Essential for Setting the Pluripotent State and Reducing Tumorigenicity of Induced Pluripotent Stem Cells
McLenachan, S., Menchón, C., Raya, Á., Consiglio, A., & Edel, M. J. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0190 · Cited by 16
Phosphatidic Acid Improves Reprogramming to Pluripotency by Reducing Apoptosis
Jiang, Y., Du, M., Wu, M., Zhu, Y., Zhao, X., Cao, X., Li, X., Long, P., Li, W., & Hu, B. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0159 · Cited by 18
Pluripotency transcription factors in the pathogenesis of colorectal cancer and implications for prognosis.
Voutsadakis, I. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.4 · Cited by 16
Changing Stem Cell Dynamics during Papillomavirus Infection: Potential Roles for Cellular Plasticity in the Viral Lifecycle and Disease
Strati, K. (2017) · Viruses · doi:10.3390/v9080221 · Cited by 15
ADAR1 Is Involved in the Regulation of Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells
Germanguz, I., Shtrichman, R., Osenberg, S., Ziskind, A., Novak, A., Domev, H., Laevsky, I., Jacob‐Hirsch, J., Feiler, Y., Rechavi, G., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0206 · Cited by 16
Epigenetics of Pluripotent Cells
Medvedev, S. P., Pokushalov, E. A., & Zakian, S. M. (2012) · Acta Naturae · doi:10.32607/20758251-2012-4-4-28-46 · Cited by 16
p53: A New Kingpin in the Stem Cell Arena
Aparicio, S. A. J. R., & Eaves, C. J. (2009) · Cell · doi:10.1016/j.cell.2009.09.004 · Cited by 16
Changes in the morphology and protein expression of germ cells and Sertoli cells in plateau pikas testes during non-breeding season
Liu, M., Cao, G., Zhang, Y., Qu, J., Li, W., Wan, X., Li, Y., Zhang, Z., Wang, Y., & Gao, F. (2016) · Scientific Reports · doi:10.1038/srep22697 · Cited by 16
Self-citation
p53-based Anti-cancer Therapies: an Empty Promise?
Desilet, N., Campbell, T. N., & Choy, F. Y. M. (2010) · Current Issues in Molecular Biology · doi:10.21775/cimb.012.143 · Cited by 16
The Janus face of pluripotent stem cells – Connection between pluripotency and tumourigenicity
Wobus, A. M. (2010) · BioEssays · doi:10.1002/bies.201000065 · Cited by 15
p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation
Pinnamaneni, J. P., Singh, V., Kim, M. B., Ryan, C. T., Pugazenthi, A., Sanagasetti, D., Mathison, M. N., Yang, J., & Rosengart, T. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-15559-y · Cited by 15
Discovery, Synthesis, and Activity Evaluation of Novel Five-Membered Sulfur-Containing Heterocyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo
Hao, E., Zhao, Y., Yu, M., Li, X.-J., Wang, K., Su, F.-Y., Liang, Y., Wang, Y., & Guo, H. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00443 · Cited by 15
Self-citation
Natural and artificial routes to pluripotency
Krueger, W. H., Swanson, L. C., Tanasijevic, B., & Rasmussen, T. P. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103199wk · Cited by 16
Identification and characterisation of Emp53, the homologue of human tumor suppressor p53, from Echinococcus multilocularis: its role in apoptosis and the oxidative stress response
Cheng, Z., Zhu, S., Wang, L., Liu, F., Tian, H., Pengsakul, T., & Wang, Y. (2015) · International Journal for Parasitology · doi:10.1016/j.ijpara.2015.02.010 · Cited by 15
Self-citation
Can controlled cellular reprogramming be achieved using microRNAs?
Sun, X., Fu, X., Han, W., Zhao, Y., & Liu, H. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.06.002 · Cited by 15
Molecular mechanisms of induced pluripotency
Kulcenty, K., Wróblewska, J., Mazurek, S., Liszewska, E., & Jaworski, J. (2015) · Contemporary oncology · doi:10.5114/wo.2014.47134 · Cited by 9
p18 inhibits reprogramming through inactivation of Cdk4/6
Zhu, S., Cao, J., Sun, H., Liu, K., Li, Y., & Zhao, T. (2016) · Scientific Reports · doi:10.1038/srep31085 · Cited by 15
Applications for Induced Pluripotent Stem Cells in Disease Modelling and Drug Development for Heart Diseases
Nakao, S., Ihara, D., Hasegawa, K., & Kawamura, T. (2020) · European Cardiology Review · doi:10.15420/ecr.2019.03 · Cited by 15
Self-citation
Expression profiling and pathway analysis of Krüppel-like factor 4 in mouse embryonic fibroblasts.
Hagos, E. G., Ghaleb, A. M., Kumar, A., Neish, A. S., & Yang, V. W. (2011) · PubMed Central · Cited by 15
Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins
Vilas, J. M., Ferreirós, A., Carneiro, C., Morey, L., Silva‐Álvarez, S. D., Fernandes, T., Abad, M., Croce, L. D., García‐Caballero, T., Serrano, M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2996 · Cited by 15
Induced Neural Stem Cells Generated from Rat Fibroblasts
Xi, G., Hu, P., Qu, C., Qiu, S., Tong, C., & Ying, Q.-L. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.003 · Cited by 14
Human pluripotent stem cells: from biology to cell therapy.
Ramirez, J.-M., Bai, Q., Dijon-Grinand, M., Assou, S., Gerbal-Chaloin, S., Hamamah, S., & de Vos, J. (2010) · World Journal of Stem Cells · doi:10.4252/wjsc.v2.i2.24 · Cited by 15
Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent Stem Cells under Mouse and Human ESC Culture Conditions
Zhang, W., Zhong, L., Wang, J., & Han, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158655 · Cited by 15
Identifying the Biphasic Role of Calcineurin/NFAT Signaling Enables Replacement of Sox2 in Somatic Cell Reprogramming
Khodeer, S., & Era, T. (2017) · Stem Cells · doi:10.1002/stem.2572 · Cited by 16
Investigation of Optimized Treatment Conditions for Acoustic-Transfection Technique for Intracellular Delivery of Macromolecules
Kim, M. G., Yoon, S., Chiu, C. T., & Shung, K. K. (2017) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2017.11.005 · Cited by 15
Clonally related diffuse large B-cell lymphoma and interdigitating dendritic cell sarcoma sharing MYC translocation
Ochi, Y., Hiramoto, N., Yoshizato, T., Ono, Y., Takeda, J., Shiozawa, Y., Yoshida, K., Kakiuchi, N., Shiraishi, Y., Tanaka, H., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.193490 · Cited by 15
Receptor interacting protein kinase 3 (RIP3) regulates iPSCs generation through modulating cell cycle progression genes
Al‐Moujahed, A., Tian, B., Efstathiou, N. E., Konstantinou, E. K., Hoang, M. V., Lin, H., Miller, J. W., & Vavvas, D. G. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101387 · Cited by 15
Absence of cyclin-dependent kinase inhibitor p27 or p18 increases efficiency of iPSC generation without induction of iPSC genomic instability
Zhan, Z., Song, L., Zhang, W., Gu, H., Cheng, H., Zhang, Y., Yang, Y., Ji, G., Feng, H., Cheng, T., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1502-8 · Cited by 14
Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency
Ferreirós, A., Pedrosa, P., Silva‐Álvarez, S. D., Triana-Martínez, F., Vilas, J. M., Picallos-Rabina, P., González, P., Gómez, M., Li, H., García‐Caballero, T., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.04.006 · Cited by 13
Células madre tumorales: una diana terapéutica en el cáncer de mama
Eguiara, A., Elorriaga, K., Rezola, R., & Martín, Á. G. (2012) · Revista de Senología y Patología Mamaria · doi:10.1016/s0214-1582(12)70024-5 · Cited by 14
Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer
Chu, P., Hou, M., Lai, J.-C., Chen, L.-F., & Lin, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081827 · Cited by 14
Metabolic control of induced pluripotency
Sinenko, S. A., & Tomilin, A. N. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1328522 · Cited by 15
Xenopatients 2.0: Reprogramming the epigenetic landscapes of patient-derived cancer genomes
Menéndez, J. A., Alarcón, T., Corominas-Faja, B., Cuyàs, E., López‐Bonet, E., Martín, Á. G., & Vellón, L. (2014) · Cell Cycle · doi:10.4161/cc.27770 · Cited by 14
Mechanisms for enhancing cellular reprogramming
Soufi, A. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.007 · Cited by 14
Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome
Soufi, A., & Zaret, K. S. (2013) · Cell Cycle · doi:10.4161/cc.24663 · Cited by 14
Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytes
Ou, M., Zhao, M., Li, C., Tang, D., Xu, Y. J., Dai, W., Sui, W., Zhang, Y., Xiang, Z., Mo, C., et al. (2021) · Biology Open · doi:10.1242/bio.053348 · Cited by 15

Authors: Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I.
Affiliations: Salk Institute for Biological Studies (US)
Corresponding author: Wahl, Geoffrey M.
Belmonte, Juan Carlos Izpisúa
ORCID: Kawamura, Teruhisa
Wahl, Geoffrey M.
Belmonte, Juan Carlos Izpisúa
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-08
Volume: 460
Issue: 7259
Pages: 1140-1144
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature08311
PMC: PMC2735889
OpenAlex: W2070672434
Cited by: 1,115
References: 40
Citations by year: 2026: 13 · 2025: 12 · 2024: 30 · 2023: 34 · 2022: 31 · 2021: 36 · 2020: 29 · 2019: 41 · 2018: 55 · 2017: 60 · 2016: 65 · 2015: 77 · 2014: 96 · 2013: 111 · 2012: 136
FWCI: 57.10
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (R33HL088293)
National Cancer Institute (R01CA100845, R01CA061449)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: p53, somatic cell reprogramming, induced pluripotent stem cells, Oct4, SOX2, p21, Nutlin-3, reprogramming efficiency, malignant transformation, fibroblasts, oncogenes, apoptosis
MeSH terms: Animals, Cells, Cultured, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Mice, Inbred C57BL, Down-Regulation, Keratinocytes, Tumor Suppressor Protein p53, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks